Vimarsana
Biggest News Aggregation in the World

Acid Synthase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acid Synthase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acid Synthase Today - Breaking & Trending Today

Harnessing redox proteomics to study metabolic regulation and stress response in lignin-fed Rhodococci | Biotechnology for Biofuels and Bioproducts - Vimarsana News

Harnessing redox proteomics to study metabolic regulation and stress response in lignin-fed Rhodococci | Biotechnology for Biofuels and Bioproducts

Rhodococci are studied for their bacterial ligninolytic capabilities and proclivity to accumulate lipids. Lignin utilization is a resource intensive process requiring a variety of redox active enzymes and cofactors for degradation as well as defense against the resulting toxic byproducts and oxidative conditions. Studying enzyme expression and regulation between carbon sources will help decode the metabolic rewiring that stymies lignin to lipid conversion in these bacteria. Herein, a redox proteomics approach was applied to investigate a fundamental driver of carbon catabolism and lipid anabol...

Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma - Vimarsana News

Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces the completion of enrollment of 120 patients in the Phase III registration...